- ►nih.gov - Free from Publisher RM Bergenstal, M Johnson, MA Powers, A … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH AND DESIGN METHODS—This 24-week, multicenter, randomized, controlled
study compared two algorithms for adjusting mealtime (glulisine) insulin along
with a standard algorithm for adjusting background (glargine) insulin in ... Cited by 20 - Related articles - All 10 versions
R Qayyum, S Bolen, N Maruthur, L Feldman, … - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: Evidence comparing premixed insulin analogues (a mixture of
rapid-acting and intermediate-acting insulin analogues) with other antidiabetic
agents is urgently required to guide appropriate therapy. Cited by 20 - Related articles - All 8 versions
M Monami, N Marchionni, E Mannucci - Diabetes research and clinical practice, 2008 - Elsevier A total of 14 RCTs was retrieved and included in the analysis. Long-acting
analogues did not produce any significant improvement of HbA1c, in comparison
with NPH human insulin. When trials with different analogues were analysed ... Cited by 5 - Related articles - All 14 versions
FJ Ampudia-Blasco, J Rosenstock - Avances en diabetología, 2008 - sediabetes.org Resumen La diabetes tipo 2 se caracteriza por una resistencia a la insulina y un
deterioro progresivo de la función beta pancreática. Cuando dicha función se
altera, muchos pacientes con diabetes mellitus tipo 2 ne- cesitarán ... Cited by 4 - Related articles - View as HTML - All 6 versions
- ►leicestershirediabetes.org.uk [PDF] RR Holman, AJ Farmer, MJ Davies, JC Levy, … - New England Journal of Medicine, 2009 - content.nejm.org From the Diabetes Trials Unit (RRH, JLD, JFK, SKP), Oxford Centre for Diabetes,
Endocrinology and Metabo- lism (RRH, AJF, JCL, JLD, JFK, SKP), and the
Department of Primary Health Care and National Institute for Health ... Cited by 2 - Related articles - All 8 versions
DS Lasserson, P Glasziou, R Perera, RR … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis We compared the effect of biphasic, basal or prandial
insulin regimens on glucose control, clinical outcomes and adverse events in
people with type 2 diabetes. Methods We searched the Cochrane Library, ... Cited by 2 - Related articles - All 2 versions
B Sheldon, D Russell-Jones, J Wright - Diabetes, Obesity and Metabolism, 2009 - interscience.wiley.com Insulin analogues were developed to try and achieve more physiological insulin
replacement from injection in the subcutaneous site. Their pharmacokinetics and
pharmacodynamics differ from human insulin when injected subcutaneously ... Cited by 2 - Related articles - All 3 versions
D Raccah - Diabetes, Obesity and Metabolism, 2008 - interscience.wiley.com In the early treatment of type 2 diabetes mellitus (T2DM), the addition of a
basal insulin, such as insulin glargine, to existing oral therapy can help
patients attain recommended glycaemic control targets, including ... Cited by 2 - Related articles - All 5 versions
J Fahrbach, S Jacober, H Jiang, S Martin, 2008 - ncbi.nlm.nih.gov The DURABLE (Assessing the DURAbility of Basal vs Lispro Mix 75/25 Insulin
Efficacy) trial will compare the ability of glargine once daily vs lispro mix
75/25 (75% insulin lispro protamine suspension, 25% lispro) twice daily ... Cited by 2
MJP van Avendonk, G Rutten - Diabetes, Obesity and Metabolism, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - All 3 versions
